Floris H P van Velden
Overview
Explore the profile of Floris H P van Velden including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
2580
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boellaard R, Zwezerijnen G, Buvat I, Champion L, Hovhannisyan-Baghdasarian N, Orlhac F, et al.
J Nucl Med
. 2025 Mar;
PMID: 40081961
Measuring total metabolic tumor volume (TMTV) on F-FDG PET/CT images in clinical practice requires a fast, reliable, and easy-to-perform multilesional segmentation workflow. We conducted a field test to derive total...
2.
van der Heijden W, van Velden F, Hemke R, Doorschodt T, Boellaard R, van der Laken C, et al.
EJNMMI Phys
. 2025 Mar;
12(1):20.
PMID: 40059265
Purpose: Spondyloarthritis (SpA) is a chronic inflammatory rheumatic disease which involves the axial skeleton. Quantitative sodium fluoride-18 (Na[F]F) PET/CT is a new imaging approach promising for accurate diagnosis and treatment...
3.
van de Burgt A, Dibbets-Schneider P, Kotasidis F, de Geus-Oei L, Rietbergen D, van Velden F
Phys Med
. 2025 Feb;
131:104935.
PMID: 39956005
Purpose: To assess the lower [F]FDG limit in administered activity and/or scan time reduction capabilities of a digital-BGO 32-cm axial field-of-view PET system while being compliant with current and updated...
4.
Kleiburg F, de Geus-Oei L, Spijkerman R, Noortman W, van Velden F, Manohar S, et al.
Eur Radiol
. 2025 Jan;
PMID: 39843627
Objective: Metastatic castration-resistant prostate cancer (mCRPC) is a heterogeneous disease with varying survival outcomes. This study investigated whether baseline PSMA PET/CT parameters are associated with survival and treatment response. Methods:...
5.
van de Burgt A, van Velden F, Corion C, Collarino A, Olmos R, Smit F, et al.
Mol Imaging Biol
. 2024 Nov;
26(6):926-933.
PMID: 39516430
Purpose: This study evaluates the semi-quantitative single-photon emission computed tomography (SPECT) parameters of prone SPECT using [Tc]Tc-sestamibi and compares them with Molecular Breast Imaging (MBI)-derived semi-quantitative parameters for the potential...
6.
Ende T, Kuijper S, Widaatalla Y, Noortman W, van Velden F, Woodruff H, et al.
Int J Radiat Oncol Biol Phys
. 2024 Oct;
121(4):963-974.
PMID: 39424077
Purpose: The value of integrating clinical variables, radiomics, and tumor-derived cell-free DNA (cfDNA) for the prediction of survival and response to chemoradiation of patients with resectable esophageal adenocarcinoma is not...
7.
Ciggaar I, de Muynck L, de Geus-Oei L, van Velden F, de Kroon C, Arias-Bouda L, et al.
Nucl Med Biol
. 2024 Sep;
138-139:108952.
PMID: 39326323
Purpose: The selection for either primary or interval cytoreductive surgery (CRS) in patients with epithelial ovarian cancer (EOC) is currently based on imaging techniques like computed tomography (CT), [F]fluorodeoxyglucose-positron emission...
8.
Polomski E, Kapiteijn E, Heemelaar J, van der Kolk A, Kalisvaart T, van de Burgt A, et al.
Atherosclerosis
. 2024 Sep;
398:118595.
PMID: 39307054
Background And Aims: Immune checkpoint inhibitors (ICIs) revolutionized cancer treatment. However, ICIs may increase the immune response to non-tumor cells, possibly resulting in increased arterial inflammation, raising the risk of...
9.
Droste M, van Velden F, van Oosterom M, Luijk V, Burgmans M, Buckle T, et al.
Cancers (Basel)
. 2024 Aug;
16(15).
PMID: 39123421
Computer tomography (CT)-guided percutaneous core biopsies are currently the gold standard in diagnostic procedures for patients with bone lesions of unknown kind. CT-guided biopsies can lead to misdiagnosis or repetition...
10.
Ruytenberg T, Ciggaar I, Peters I, Noortman W, Dibbets-Schneider P, de Muynck L, et al.
Mol Imaging Biol
. 2024 May;
26(4):577-584.
PMID: 38775919
Purpose: To describe the pharmacokinetic properties of the [F]fluoro-polyethylene glycol(PEG)-folate radiotracer in PET/CT imaging of patients with advanced stage epithelial ovarian cancer (EOC). Procedures: In five patients with advanced EOC...